Ocumetics Technology Corp. - TSX.V: OTC

Huge thanks to CEM for an amazing conference. The 1:1 meetings were engaging and a fantastic way to connect with the capital markets community. #WhistlerCapitalEvent #CEM #CapitalMarkets #InvestorMeetings #Ocumetics

FLASHBACK FRIDAY - ICYMI Ocumetics Webinar 02 04 26 - First-In-Human Study Three-Month Results Update Watch Video - youtu.be/E_5egT5PRxo Listen To Podcast - howardgroupinc.com/podcasts/ $otc #ocumetics #podcasts #howardgroupinc #ir #tsx TSX-V:OTC | OCTQB: OTCFF | FSE: 2QB0

Dean Burns, President and CEO of Ocumetics, will be attending investor meetings at the CEM 16th Annual Whistler Capital Event hosted at the beautiful Fairmont Chateau Whistler, BC. @capitalevent #tsx #tmx $otc

“These first-in-human results are exactly what we were aiming to demonstrate at this stage: safe implantation, reliable delivery, and strong visual outcomes,” said Dean Burns, President and CEO of Ocumetics. TSXV: OTC | OTCQB: OTCFF | FRA: 2QBO $OTC

From All Of Us @ocumetics We Wish You A Merry Christmas & Happy New Year #eyesight #christmas #accommodatingintraocularlens

Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations - Read the full release - ocumetics.com

@investorbrkt Thank you for the opportunity to attend the CEM Muskoka Conference!

Can a lens replace your #glasses forever? @OcumeticsTech (TSXV: $OTC | OTCQB: $OTCFF | FRA: 2QBO) is betting on it. Ocumetics is developing an advanced intraocular lens designed to work with the #eye’s own muscles, enabling users to see clearly from far to near without glasses or #contacts. The implications for the $158B #eyewear market could be massive. Early clinical trials are showing functional distance #vision of 20/40 or better, with signs of near-vision improvement after just one month. Ocumetics is targeting a massive fast-growing market where 24 million #cataract surgeries are done globally each year, and the intraocular lens segment is projected to surpass $6B by 2030. With decades of research behind its platform that could redefine how people see the world, Ocumetics earned its place as a Top 5 Pick at the 2025 CEM Muskoka. Watch the video clip as @RyanIverson_ discusses why Ocumetics is gaining momentum with investors. Want to be the first to access breakout companies before the broader market catches on? Subscribe to the Investor Breakout newsletter: bit.ly/4gj3yaY __ @CapitalEvent @MarketOneMedia @FarhanLalani @NCurrie Please see our disclaimer: bit.ly/4qur8b2

Ocumetics is pleased to announce it will be presenting at the Centurion One Capital 3rd Annual Bahamas Summit, a two day invitation only event taking place at the exclusive Rosewood Baha Mar Hotel from Oct 28th to Oct 29th, 2025, in Nassau, Bahamas. #Ocumetics #VisionInnovation

Ocumetics mentioned in Needham Report Searching For The Holy Grail - Accommodating Intraocular Lens (AIOL) Deep Dive - LINK - @ocumetics.com&source=mail" target="_blank" rel="nofollow noopener">needham.bluematrix.com/sellside/Email…

We’re heading to NYC! 🚀 Catch us at the Maxim Growth Summit (Oct 22–23, Hard Rock Hotel) — where top innovators and institutions unite to drive the next wave of growth. #Ocumetics #VisionInnovation

Dean Burns, CEO explains how Ocumetics’ first human trials are proving that it’s revolutionary lens implant is not only safe — it’s transforming lives. Full Video - youtu.be/bcardmns2c0 #Ocumetics #VisionInnovation